Chemotherapy in the management of intraocular lymphoma

James A. Strauchen, Jack Dalton, Alan H. Friedman

Research output: Contribution to journalArticlepeer-review

53 Scopus citations


Six patients with intraocular (vitreous) lymphomas were treated with high‐dose intravenous cytosine arabinoside (Ara‐C). Four patients were previously untreated, one patient had previously received ocular and central nervous system radiation therapy and relapsed, and one patient had previously received chemotherapy for systemic lymphoma. Five responses were observed: one complete and four partial. High‐dose Ara‐C is active in intraocular (vitreous) lymphoma, but complete response is uncommon. Adjunctive use of Ara‐C in combination with ocular irradiation may be a useful form of therapy in this uncommon lymphoma.

Original languageEnglish
Pages (from-to)1918-1921
Number of pages4
Issue number10
StatePublished - 15 May 1989
Externally publishedYes


Dive into the research topics of 'Chemotherapy in the management of intraocular lymphoma'. Together they form a unique fingerprint.

Cite this